1. P571 Effectiveness and safety of Ustekinumab for induction of remission in patients with Crohn's disease: a multi-centre Israeli study. (25th January 2019) Authors: Bar-Gil Shitrit, A; Siterman, M; Waterman, M; Hirsh, A; Khoury, T; Schwartz, D; Zittan, E; Adler, J; Koslowsky, B; Avni-Biron, I; Chowers, Y; Ron, Y; Israeli, E; Ungar, B; Yanai, H; Maharshak, N; Ben-Horin, S; Ben-Ya'acov, A; Eliakim, R; Dotan, I Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P508 Does corticosteroid therapy affect prognosis in inflammatory bowel disease patients hospitalised with Clostridium difficile infection?. (25th January 2019) Authors: Bar Yoseph, H; Daoud, H; Ben Hur, D; Chowers, Y; Waterman, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S367 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P082 A cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of IBD patients. (16th January 2018) Authors: Gaujoux, R; Starosvetsky, E; Maimon, N; Vallania, F; Bar-Yoseph, H; Pressman, S; Weisshof, R; Goren, I; Waterman, M; Yanai, H; Dotan, I; Sabo, E; Chowers, Y; Khatri, P; Shen-Orr, S S Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P486 Response to vedolizumab therapy in patients with inflammatory bowel disease: Impact of drug levels, anti-drug antibodies and α4β7 target occupancy. (16th January 2018) Authors: Ungar, B; Kopylov, U; Yavzori, M; Fudim, E; Picard, O; Lahat, A; Coscas, D; Waterman, M; Haj-Natour, O; Orbach-Zingboim, N; Mao, R; Chen, M; Chowers, Y; Eliakim, R; Ben-Horin, S Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DOP72 The association of anti-tumor necrosis factor and thiopurine therapy with the risk of lymphoma among Inflammatory Bowel Disease patients: A nation-wide study from the epi-IIRN. (21st January 2022) Authors: Waterman, M; Lavi, I; Harel, S; Focht, G; Loewenberg Weisband, J; Greenfeld, S; Kariv, R; Ledderman, N; Matz, E; Keinan-Boker, L; Eizenstein, S; Dotan, I; Turner, D; Levi, Z Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P275 Course of COVID-19 in patients with Inflammatory Bowel Diseases treated with biologics: the Israeli experience. (27th May 2021) Authors: Lichtenstein, L; Koslowsky, B; Avni-Biron, I; Ovadia, B; Ben-Bassat, O; Naftali, T; Kopylov, U; Haberman, Y; Banai Eran, H; Eliakim, R; Lahat-Zok, A; Hirsch, A; Zittan, E; Maharshak, N; Waterman, M; Israeli, E; Goren, I; Ollech, J E; Yanai, H; Ungar, B Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P570 Prediction of achieving remission in Crohn's disease patients by abdominal Imaging. (27th May 2021) Authors: Meringer, H; Tzadok, R; Mercer, D; Handler, M; Barnes, S; Waterman, M; Abadi, S; Margalit Yehuda, R; Kopylov, U; Amitai, M M; Bar-Gil Shitrit, A; Sheynkman, G; Zittan, E; Maharshak, N Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P292 Complications in elderly-onset Inflammatory Bowel Diseases – A population-based study from the epidemiological database of the Israeli IBD Research Nucleus (Epi-IIRN). (30th January 2023) Authors: Ben Hur, D; Lebedenko, B; Issaschar, G; Moshe, R; Lujan, R; Focht, G; Loewenberg Weisband, Y; Kariv, R; Ledderman, N; Matz, E; Dotan, I; Turner, D; Pinto, G; Waterman, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P552 Anti-TNF Treatment and Risk of Atrial Fibrillation in Inflammatory Bowel Disease Patients. (30th January 2023) Authors: Cohen, Y; Fischman, M; Waterman, M; Dolnikov, K; Azzam, Z S; Ghersin, I Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗